Prognosis

70 Expert Conversations

    70 Expert Conversations
    Immunotherapy in breast cancer. Immunotherapy is not a magic treatment. 11
    0.00 NIS
    Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10
    0.00 NIS
    When can breast cancer be considered cured? Is cure possible for breast cancer? 5
    0.00 NIS
    Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11
    0.00 NIS
    How to select drug combinations for multiple myeloma treatment? 7
    0.00 NIS
    Multiple myeloma. Patient’s story: elderly woman and ‘last hope’ CAR T-cell therapy. 13
    0.00 NIS
    Multiple myeloma. FAQ: Immunization, Vitamin D and bone health, quality of life. 12
    0.00 NIS
    Future in multiple myeloma treatment. When will it be a ‘curable disease’? 11
    0.00 NIS
    Castleman Disease. Subtypes and treatment options. 10
    0.00 NIS
    Multiple myeloma. Minimal Residual Disease evaluation. Prognosis. 9
    0.00 NIS
    Multiple myeloma. Progress and challenges of treatment. 1
    0.00 NIS
    FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15
    0.00 NIS
    Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10
    0.00 NIS
    How NASH differs from NAFLD. What drives progression to NASH? 5
    0.00 NIS
    Can fatty liver disease be reversed? NAFLD and NASH treatment. 4
    0.00 NIS
    Pediatric arthritis FAQ. Can a child with arthritis lead a normal life? 16
    0.00 NIS
    Arthritis in children. FAQ. Nutrition in arthritis. Will my child outgrow arthritis? 15
    0.00 NIS
    Multisystem inflammatory syndrome in children. MIS-C. Prognosis and recovery. 3
    0.00 NIS
    Mesothelioma. Clinical case. Example of importance of enrollment into clinical trials. 11
    0.00 NIS
    Mesothelioma. Importance 
for patients of enrollment into clinical trials. 10
    0.00 NIS
    Future in mesothelioma treatment. 9
    0.00 NIS
    Mesothelioma. Surgical treatment options. 4
    0.00 NIS
    Coronary artery calcium score. Best universal predictor of heart disease? 9
    0.00 NIS
    How to prepare for spine surgery? 8
    0.00 NIS
    Multiple Sclerosis. Innate and Adaptive Immune systems interact. 3
    0.00 NIS
    Why ovarian cancer treatment is inadequate? Top surgeon reviews problems in cancer surgery. 15
    0.00 NIS
    Clinical case. Tennis player with locked knee. Osteochondritis dissecans (OCD). 9
    0.00 NIS
    Every cancer patient must be evaluated by Tumor Board. Multidisciplinary Team. 9-2
    0.00 NIS
    Colorectal cancer prognosis. Adaptive clinical trials. Prediction of response to treatment. 8-1
    0.00 NIS
    Chemotherapy of rectal cancer. Capecitabine (Xeloda) and oxaliplatin 5-FU. Controversies. 5-3
    0.00 NIS
    Colon cancer surgery options. Best therapy for colorectal cancer. 8
    0.00 NIS
    Prognosis in Stage 4 metastatic colon cancer. 10-year survival for 30% of patients. 6
    0.00 NIS
    Liver metastases in Stage 4 colon cancer. Cure and long-term survival are possible. 3
    0.00 NIS
    How to select patients for surgical resection of liver metastases? Stage 4 colorectal cancer. 2
    0.00 NIS
    Myeloproliferative disorder. Diagnosis and treatment. 4
    0.00 NIS
    Myelodysplastic syndrome. Treatment and prognosis. 3
    0.00 NIS
    Glioblastoma. High-grade Glioma. How treatment options improved recently? 10
    0.00 NIS
    Recently viewed Expert Conversations